Skip to search formSkip to main contentSkip to account menu

Sylatron

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

peginterferon alfa-2b
peginterferon alfa-2b 0.2 MG Injection [Sylatron]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A phase II multicenter study evaluating combination immunotherapy with pembrolizumab and peginterferon alfa-2b for advanced cholangiocarcinoma.
TPS507Background: No effective therapy is available for patients (pts) with advanced cholangiocarcinoma (CC) after disease… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)